Data for (Study ST003286)
(Analysis AN005383)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 | F16 | F17 | F18 | F19 | F20 | F21 | F22 | F23 | F24 | F25 | F26 | F27 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acetate | 0.3740 | 0.7587 | 0.7193 | 0.6323 | 2.3726 | 2.3788 | 1.0306 | 2.5256 | 1.9707 | 0.2440 | 0.5318 | 1.7404 | 0.4529 | 2.1681 | 1.9426 | 0.8172 | 2.9216 | 1.2708 | 0.0799 | 0.0667 | 0.0959 | 0.3199 | 0.3128 | 0.2500 | 0.3044 | 0.3374 | 0.3811 |
Alanine | 0.6451 | 0.5954 | 0.5716 | 1.1226 | 1.2245 | 1.0902 | 1.4416 | 1.2667 | 1.2419 | 1.0685 | 0.3485 | 1.2316 | 0.9164 | 1.2985 | 0.8588 | 0.7828 | 1.4336 | 0.9096 | 0.5347 | 0.4885 | 0.5135 | 1.4060 | 1.3197 | 1.1501 | 1.1207 | 1.0507 | 1.3681 |
Arginine | 0.7903 | 1.8040 | 0.7184 | 1.0967 | 1.4367 | 1.2251 | 1.4354 | 1.5810 | 0.9425 | 0.3625 | 0.3180 | 0.4942 | 1.3616 | 1.0848 | 1.3176 | 1.2152 | 1.2836 | 0.7342 | 0.9345 | 0.8296 | 0.8290 | 0.9299 | 0.9856 | 0.8195 | 1.0277 | 0.7783 | 0.6639 |
Aspartate | 1.6412 | 1.4637 | 0.9226 | 3.0537 | 1.3133 | 2.4335 | 2.1148 | 2.0997 | 2.1286 | 0.3752 | 0.1983 | 0.3830 | 0.5725 | 0.7207 | 0.9318 | 1.1650 | 0.7647 | 0.7911 | 0.4699 | 0.4372 | 0.2982 | 0.6474 | 0.4230 | 0.4116 | 0.3970 | 0.4937 | 0.3488 |
Choline | 1.9631 | 2.3484 | 1.7766 | 2.2325 | 2.5387 | 1.5991 | 1.8389 | 1.7846 | 1.3694 | 0.2475 | 0.2398 | 0.2907 | 0.6382 | 0.3354 | 0.3624 | 0.5667 | 0.2694 | 0.5622 | 0.5902 | 0.6572 | 0.7459 | 1.0813 | 0.6629 | 0.5657 | 0.5562 | 0.5759 | 0.6010 |
Cystine | 1.2536 | 1.2895 | 1.1904 | 1.4539 | 1.0025 | 1.1003 | 1.5780 | 1.0260 | 1.0787 | 0.7205 | 0.4766 | 1.3206 | 1.3504 | 0.7365 | 1.3944 | 1.4826 | 0.7082 | 0.9309 | 0.7336 | 0.8295 | 0.6891 | 0.8680 | 0.9942 | 0.6469 | 0.6886 | 0.6195 | 0.8368 |
Formate | 0.3337 | 0.6566 | 0.4061 | 0.7575 | 3.7863 | 0.5721 | 0.3716 | 0.4691 | 0.5634 | 2.7076 | 0.5550 | 1.6428 | 0.6479 | 1.9361 | 2.0934 | 1.1529 | 2.1930 | 1.9925 | 0.5188 | 0.3967 | 0.4847 | 0.4430 | 0.5508 | 0.4350 | 0.4586 | 0.4099 | 0.4646 |
Fumarate | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0.7777 | 0.7777 | 1.6950 | 1.2031 | 0.8973 | 0.6381 | 0.3058 | 0.8309 | 0.4188 | 1.3892 | 1.3560 | 1.3095 | 0.8575 | 0.9970 | 1.1100 | 1.2430 | 1.1965 | 0.9970 |
Glucose | 1.0010 | 0.7625 | 0.9792 | 0.8305 | 0.6452 | 0.8866 | 0.7803 | 0.6649 | 0.7649 | 1.0966 | 0.9867 | 1.0812 | 1.0886 | 1.0363 | 1.0918 | 1.0318 | 1.0974 | 1.0645 | 1.1219 | 1.1302 | 1.1278 | 1.1338 | 1.1200 | 1.1337 | 1.0870 | 1.1155 | 1.1402 |
Glutamate | 0.4584 | 0.5325 | 0.5177 | 1.2718 | 1.5609 | 1.4144 | 1.1490 | 1.1141 | 0.6013 | 0.8414 | 0.7596 | 1.5490 | 1.0046 | 1.4199 | 1.8723 | 1.1688 | 1.3613 | 0.8751 | 0.8163 | 0.8601 | 0.9019 | 0.9498 | 1.0613 | 0.7882 | 0.6117 | 0.6558 | 0.8827 |
Glutamine | 0.5408 | 0.3235 | 0.2222 | 0.9535 | 0.2614 | 0.3854 | 1.1339 | 0.5325 | 1.0462 | 1.3907 | 1.3928 | 0.9836 | 1.2623 | 0.9507 | 1.2235 | 1.3565 | 1.0470 | 1.3320 | 1.2261 | 1.2028 | 1.1517 | 1.2177 | 1.2697 | 1.0666 | 1.0485 | 1.2106 | 1.2681 |
Glycine | 0.7205 | 0.8831 | 0.6549 | 1.9055 | 1.6018 | 1.5917 | 1.2678 | 1.3361 | 1.3694 | 0.6160 | 0.3049 | 1.0760 | 1.8893 | 0.2970 | 0.7289 | 1.6596 | 0.8210 | 1.0480 | 0.4877 | 0.6550 | 0.5594 | 0.8857 | 0.4836 | 0.6084 | 0.6737 | 1.5676 | 1.3074 |
Histidine | 0.7260 | 0.6725 | 0.6262 | 0.5154 | 0.7275 | 0.5585 | 0.6979 | 0.6584 | 0.6289 | 0.9415 | 0.6178 | 1.3100 | 1.1801 | 0.9898 | 1.2243 | 1.3990 | 1.1909 | 1.3755 | 1.3114 | 0.9781 | 1.2147 | 1.3872 | 1.3708 | 1.1649 | 1.2787 | 1.0555 | 1.1982 |
Isoleucine | 0.4632 | 0.7047 | 0.5144 | 0.9197 | 0.6330 | 0.9835 | 0.7700 | 0.8213 | 0.8583 | 1.0791 | 0.8506 | 0.8484 | 1.1963 | 0.9015 | 1.1068 | 1.4118 | 1.0680 | 1.3583 | 1.3097 | 1.1368 | 1.2082 | 1.2217 | 1.3270 | 1.0695 | 1.2148 | 1.0283 | 0.9954 |
Lactate | 0.3120 | 0.4418 | 0.2892 | 0.7238 | 1.8759 | 1.7172 | 0.8359 | 1.2311 | 0.9331 | 0.5098 | 0.5521 | 0.6170 | 0.9520 | 2.5366 | 2.5187 | 0.7450 | 2.5221 | 0.6472 | 0.7835 | 0.7498 | 0.7599 | 0.7854 | 0.8529 | 0.7914 | 0.7842 | 0.7323 | 0.8001 |
Leucine | 0.8742 | 0.7758 | 0.7412 | 1.0496 | 1.1494 | 0.7437 | 0.7627 | 0.8171 | 0.8934 | 1.0937 | 0.8049 | 0.8481 | 1.1549 | 1.1219 | 1.2691 | 1.3252 | 1.1973 | 1.3480 | 0.5460 | 0.5428 | 0.5207 | 1.3873 | 1.3315 | 1.0618 | 1.3085 | 1.2162 | 1.1152 |
Lysine | 0.4161 | 0.4564 | 0.5367 | 0.8500 | 0.7276 | 0.5630 | 0.8578 | 1.1225 | 0.7423 | 1.0313 | 0.7822 | 0.8636 | 1.0973 | 0.9173 | 1.2668 | 1.3666 | 1.0794 | 0.8076 | 1.4320 | 1.3057 | 1.2956 | 1.2119 | 1.2285 | 1.1978 | 1.2743 | 1.3665 | 1.2031 |
Methionine | 2.1375 | 1.8435 | 0.3840 | 0.9677 | 1.1241 | 0.8388 | 0.6327 | 0.8548 | 0.7818 | 0.8391 | 0.7912 | 1.0937 | 0.8305 | 0.8094 | 0.8190 | 1.3678 | 0.9341 | 0.9360 | 1.2531 | 0.9574 | 1.0148 | 1.0974 | 1.0075 | 0.8066 | 1.0747 | 0.9581 | 0.8447 |
myo-Inositol | 0.8738 | 1.3471 | 0.8507 | 0.5902 | 1.0261 | 1.0407 | 1.0361 | 1.1594 | 1.0626 | 0.9407 | 0.3963 | 0.7323 | 1.0808 | 0.6118 | 0.7474 | 0.6980 | 0.5265 | 0.5954 | 1.4491 | 1.5012 | 0.9796 | 1.3056 | 1.2217 | 1.2030 | 1.1645 | 1.2374 | 1.6222 |
Nicotinurate | 0.5600 | 0.6957 | 0.2617 | 0.8960 | 0.5434 | 0.9098 | 0.6255 | 0.7319 | 0.4785 | 1.6328 | 0.9415 | 1.5117 | 1.0877 | 1.1494 | 1.4614 | 1.2136 | 1.0325 | 1.1925 | 1.1153 | 1.2843 | 1.1039 | 1.2469 | 1.1746 | 1.0780 | 1.0227 | 1.0991 | 0.9496 |
Phenylalanine | 0.8036 | 1.3688 | 1.1199 | 0.9778 | 1.0680 | 0.9337 | 0.7258 | 0.9211 | 0.7015 | 1.1204 | 0.8433 | 1.0467 | 0.9588 | 0.9257 | 1.0270 | 1.2480 | 0.9040 | 1.1859 | 1.1345 | 1.0434 | 1.0527 | 1.0817 | 1.0879 | 0.9055 | 0.9630 | 0.8301 | 1.0214 |
Pyroglutamate | 0.6867 | 0.7226 | 1.5041 | 0.8204 | 1.0406 | 1.2580 | 1.2652 | 1.3305 | 0.7164 | 0.8586 | 0.7956 | 0.8578 | 0.9477 | 0.9777 | 1.0537 | 1.0010 | 1.1576 | 1.0543 | 1.1615 | 0.9844 | 1.0160 | 0.8573 | 1.1977 | 0.7651 | 1.0612 | 1.0287 | 0.8797 |
Pyruvate | 2.9320 | 1.1040 | 0.6789 | 1.9970 | 1.2212 | 0.9848 | 3.3436 | 1.1866 | 2.1046 | 0.1913 | 0.6561 | 1.3275 | 0.3805 | 1.5724 | 1.4789 | 0.3011 | 1.4231 | 1.4461 | 0.1730 | 0.1573 | 0.1897 | 0.3687 | 0.3871 | 0.3213 | 0.3995 | 0.3374 | 0.3363 |
Serine | 0.5657 | 0.5382 | 0.4471 | 1.3279 | 0.9528 | 1.3035 | 1.1640 | 1.3185 | 1.2615 | 0.4923 | 0.1693 | 0.2226 | 1.1331 | 0.3878 | 0.5248 | 1.0778 | 0.2613 | 1.5689 | 1.5498 | 1.4319 | 1.3913 | 1.3591 | 2.3145 | 0.6380 | 0.7680 | 1.1371 | 1.6930 |
Threonine | 0.5428 | 0.9500 | 0.5856 | 1.1519 | 1.2011 | 0.5934 | 0.8416 | 0.7781 | 1.0111 | 0.6370 | 0.2826 | 0.6946 | 1.4424 | 0.1918 | 0.3265 | 2.1597 | 0.1795 | 0.3507 | 1.6507 | 1.4206 | 1.5831 | 1.5542 | 1.1100 | 1.3211 | 1.6568 | 1.4807 | 1.3024 |
Tryptophan | 0.9791 | 1.2806 | 0.7063 | 0.9492 | 1.1517 | 0.6484 | 0.9038 | 0.6546 | 0.7063 | 1.4899 | 1.4538 | 1.1336 | 0.8465 | 0.8888 | 0.7960 | 1.0751 | 0.7051 | 0.8826 | 1.0695 | 0.9605 | 1.3616 | 1.0358 | 1.2439 | 0.9966 | 1.0333 | 1.1629 | 0.8845 |
Tyrosine | 0.5157 | 0.6203 | 0.3956 | 1.1263 | 1.3704 | 1.3537 | 0.9173 | 1.2704 | 1.0030 | 0.9232 | 0.6010 | 0.8981 | 1.1253 | 0.8876 | 1.0141 | 1.3462 | 1.0692 | 1.3310 | 1.0881 | 1.0484 | 0.9884 | 1.0705 | 1.1375 | 0.9593 | 0.9736 | 1.0082 | 0.9575 |
Valine | 1.5602 | 1.4988 | 1.3693 | 0.8497 | 0.6937 | 0.5498 | 0.6468 | 0.6152 | 0.6783 | 1.2469 | 0.7089 | 1.0771 | 1.1140 | 0.8828 | 0.8602 | 1.0981 | 0.8823 | 1.2375 | 1.1941 | 0.9990 | 1.0715 | 1.1522 | 1.1197 | 0.9749 | 1.0212 | 0.9649 | 0.9332 |
Factors:
F1 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab |
F2 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab |
F3 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment |
F4 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab |
F5 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab |
F6 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment |
F7 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab |
F8 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab |
F9 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment |
F10 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab |
F11 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab |
F12 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment |
F13 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab |
F14 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab |
F15 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment |
F16 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab |
F17 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab |
F18 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment |
F19 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab |
F20 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab |
F21 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment |
F22 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab |
F23 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab |
F24 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment |
F25 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab |
F26 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab |
F27 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment |